ChromaDex 将来の成長
Future 基準チェック /46
ChromaDexは、81.8%と18.1%でそれぞれ年率81.8%で利益と収益が成長すると予測される一方、EPSはgrowで82.7%年率。
主要情報
81.8%
収益成長率
82.7%
EPS成長率
| Life Sciences 収益成長 | 18.8% |
| 収益成長率 | 18.1% |
| 将来の株主資本利益率 | n/a |
| アナリストカバレッジ | Low |
| 最終更新日 | 06 Nov 2024 |
今後の成長に関する最新情報
Recent updates
ChromaDex's (NASDAQ:CDXC) Solid Earnings Are Supported By Other Strong Factors
Nov 07
Revenues Tell The Story For ChromaDex Corporation (NASDAQ:CDXC) As Its Stock Soars 70%
Nov 05ChromaDex Corporation (NASDAQ:CDXC) Stock Rockets 25% But Many Are Still Ignoring The Company
Jul 25Shareholders Will Likely Find ChromaDex Corporation's (NASDAQ:CDXC) CEO Compensation Acceptable
Jun 15Positive Sentiment Still Eludes ChromaDex Corporation (NASDAQ:CDXC) Following 26% Share Price Slump
Jun 05Should You Think About Buying ChromaDex Corporation (NASDAQ:CDXC) Now?
Apr 05Not Many Are Piling Into ChromaDex Corporation (NASDAQ:CDXC) Just Yet
Feb 28ChromaDex Corporation's (NASDAQ:CDXC) Intrinsic Value Is Potentially 85% Above Its Share Price
Jan 29Market Cool On ChromaDex Corporation's (NASDAQ:CDXC) Revenues
Jun 08We're Hopeful That ChromaDex (NASDAQ:CDXC) Will Use Its Cash Wisely
Mar 31ChromaDex inks new commercial supply agreement for its Niagen ingredient with Nestlé
Oct 11ChromaDex forms JV in Asia for Tru Niagen; plans to raise $3.1M via stock sale
Oct 03ChromaDex in pact to introduce anti-aging compound in Brazil
Sep 01Ayana Bio appoints Frank Jaksch as CEO
Aug 24ChromaDex wins patent challenge as US regulator rejects Thorne Research's demand to invalidate patent
Aug 15業績と収益の成長予測
| 日付 | 収益 | 収益 | フリー・キャッシュフロー | 営業活動によるキャッシュ | 平均アナリスト数 |
|---|---|---|---|---|---|
| 12/31/2026 | 136 | 13 | 15 | 15 | 2 |
| 12/31/2025 | 118 | 10 | 11 | 11 | 4 |
| 12/31/2024 | 97 | 3 | 4 | 6 | 5 |
| 9/30/2024 | 92 | 1 | 4 | 4 | N/A |
| 6/30/2024 | 86 | -1 | 1 | 1 | N/A |
| 3/31/2024 | 83 | -4 | 5 | 5 | N/A |
| 12/31/2023 | 84 | -5 | 7 | 7 | N/A |
| 9/30/2023 | 83 | -6 | 6 | 6 | N/A |
| 6/30/2023 | 81 | -6 | 2 | 2 | N/A |
| 3/31/2023 | 77 | -11 | -6 | -5 | N/A |
| 12/31/2022 | 72 | -17 | -15 | -15 | N/A |
| 9/30/2022 | 69 | -20 | -20 | -20 | N/A |
| 6/30/2022 | 69 | -28 | -22 | -22 | N/A |
| 3/31/2022 | 70 | -27 | -26 | -26 | N/A |
| 12/31/2021 | 67 | -27 | -25 | -24 | N/A |
| 9/30/2021 | 65 | -28 | -20 | -19 | N/A |
| 6/30/2021 | 62 | -23 | -17 | -17 | N/A |
| 3/31/2021 | 60 | -21 | -11 | -11 | N/A |
| 12/31/2020 | 59 | -20 | -11 | -11 | N/A |
| 9/30/2020 | 57 | -23 | -12 | -11 | N/A |
| 6/30/2020 | 55 | -26 | -16 | -15 | N/A |
| 3/31/2020 | 51 | -30 | -23 | -23 | N/A |
| 12/31/2019 | 46 | -32 | -21 | -20 | N/A |
| 9/30/2019 | 42 | -32 | -26 | -25 | N/A |
| 6/30/2019 | 38 | -33 | -23 | -22 | N/A |
| 3/31/2019 | 35 | -33 | -22 | -20 | N/A |
| 12/31/2018 | 32 | -33 | -22 | -21 | N/A |
| 9/30/2018 | 30 | -34 | -21 | -20 | N/A |
| 6/30/2018 | 28 | -29 | N/A | -15 | N/A |
| 3/31/2018 | 24 | -23 | N/A | -14 | N/A |
| 12/30/2017 | 21 | -17 | N/A | -10 | N/A |
| 9/30/2017 | 18 | -10 | N/A | -6 | N/A |
| 7/1/2017 | 16 | -8 | N/A | -6 | N/A |
| 4/1/2017 | 18 | -6 | N/A | 0 | N/A |
| 12/31/2016 | 22 | -4 | N/A | -3 | N/A |
| 10/1/2016 | 22 | -3 | N/A | -4 | N/A |
| 7/2/2016 | 24 | -2 | N/A | -5 | N/A |
| 4/2/2016 | 24 | -1 | N/A | -4 | N/A |
| 1/2/2016 | 18 | -3 | N/A | -2 | N/A |
| 10/3/2015 | 22 | -3 | N/A | -2 | N/A |
| 7/4/2015 | 20 | -3 | N/A | -1 | N/A |
| 4/4/2015 | 18 | -5 | N/A | -2 | N/A |
| 1/3/2015 | 15 | -5 | N/A | -3 | N/A |
| 9/27/2014 | 13 | -5 | N/A | -4 | N/A |
| 6/28/2014 | 12 | -5 | N/A | -4 | N/A |
| 3/29/2014 | 11 | -5 | N/A | -5 | N/A |
| 12/28/2013 | 10 | -4 | N/A | -4 | N/A |
アナリストによる今後の成長予測
収入対貯蓄率: CDXCの予測収益成長率 (年間81.8% ) は 貯蓄率 ( 2.6% ) を上回っています。
収益対市場: CDXCの収益 ( 81.8% ) はUS市場 ( 15.5% ) よりも速いペースで成長すると予測されています。
高成長収益: CDXCの収益は今後 3 年間で 大幅に 増加すると予想されています。
収益対市場: CDXCの収益 ( 18.1% ) US市場 ( 9% ) よりも速いペースで成長すると予測されています。
高い収益成長: CDXCの収益 ( 18.1% ) 20%よりも低い成長が予測されています。
一株当たり利益成長率予想
将来の株主資本利益率
将来のROE: CDXCの 自己資本利益率 が 3 年後に高くなると予測されるかどうかを判断するにはデータが不十分です